The Effect of Prayer on Dyspnea Severity, Anxiety and Spiritual Well-Being in Individuals With COPD

Sponsor
Cumhuriyet University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05997394
Collaborator
(none)
90
2
8

Study Details

Study Description

Brief Summary

This study will be conducted in order to examine the effect of prayer to individuals with COPD on the severity of dyspnea, anxiety and spiritual well-being experienced by patients.

Condition or Disease Intervention/Treatment Phase
  • Other: A prayer concert will be held for the participants.
N/A

Detailed Description

This study will be conducted on people with COPD. People with COPD disease will be divided into two groups. The experimental group will be given a prayer lesson for a month. Prayer listening will not be performed to the control group. At the end of one month, the severity of dyspnea, anxiety and spiritual well-being levels of people in both groups will be re-evaluated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
It is a semi-experimental type of study. It consists of two groups: experiment and control.It is a semi-experimental type of study. It consists of two groups: experiment and control.
Masking:
Double (Participant, Investigator)
Masking Description:
The experimental and control groups will be determined by randomization method by a person other than the researcher. Participants will not know which group they are in.
Primary Purpose:
Treatment
Official Title:
The Effect of Prayer on Dyspnea Severity, Anxiety and Spiritual Well-Being in Individuals With COPD
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

Participants in this group will be given a prayer concert for a month. At the end of one month, the severity of dyspnea, anxiety and spiritual well-being levels experienced by the participants will be re-checked.

Other: A prayer concert will be held for the participants.
Participants who are in the experimental group will be given a prayer audience.

No Intervention: Control Group

There will be no prayer audience for participants in this group.

Outcome Measures

Primary Outcome Measures

  1. dyspnea 12 scale [1 month]

    as a result of 1-month prayer listening, the severity of dyspnea of the participants in the experimental group decreased.

  2. Beck anxiety scale [1 month]

    as a result of listening to prayer for 1 month, the anxiety severity of the participants in the experimental group decreased.

  3. Spiritual Well-Being Scale [1 month]

    as a result of listening to prayer for 1 month, the spiritual well-being levels of the participants in the experimental group increased.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

90 individuals (45 experiments, 45 controls) who can be contacted, who have agreed to participate in the study, who are literate, can speak Turkish, who have not participated in a similar application of this study before, who have agreed to participate in the study after being informed about the research, are 18 years old and over, with a COPD diagnosis will be taken.

Exclusion Criteria:
  • Individuals with mental and hearing problems, who have lost a family member and someone close to them in the last year, who are using tranquilizers/antidepressants, and who have experienced a traumatic situation such as divorce will be excluded from the sample.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cumhuriyet University

Investigators

  • Principal Investigator: Gülden Kaygusuz Gülden Kaygusuz, Tokat Zile Devlet Hatanesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gülden Kaygusuz, Graduate Student, Cumhuriyet University
ClinicalTrials.gov Identifier:
NCT05997394
Other Study ID Numbers:
  • SCU-SBF-GK-01
First Posted:
Aug 18, 2023
Last Update Posted:
Aug 18, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gülden Kaygusuz, Graduate Student, Cumhuriyet University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2023